The fund delivered positive absolute returns but trailed its benchmark due to an underweight in U.S. large-cap stocks. Click ...
The S&P 500 had a rough start to the week but finished on solid footing, ultimately finishing up 0.1% from last Friday. Read more here.
The average one-year price target for Galectin Therapeutics (NasdaqCM:GALT) has been revised to $11.22 / share. This is an increase of 83.33% from the prior estimate of $6.12 dated December 3, 2025.
In February, President Trump ordered the Treasury Department to stop minting pennies because the government was losing money ...
For the Tiger 21 group and other investors like them, stronger allocation to cash and fixed income signals a renewed appetite ...
Every year, the market has a theme. For 2026, I think it will be this: If you buy stocks in the new year, your return will be ...
The Tribune is tracking 11 everyday costs for Americans — eggs, milk, bread, bananas, oranges, tomatoes, chicken, ground beef ...
Headline U.S. CPI rose 2.7% year over year in November, down from a 3.0% increase in September (2). Core CPI — which strips ...
This year’s big emerging market winners have tended to offer exposure to one of 2025’s two winning trends – AI-focused tech ...
The Dow Jones Industrial Average, the S&P 500, and the Nasdaq Composite rose Friday as the stock market bet on Fed rates cuts and the tech rally rolled on.
The Fundstrat Granny Shots US Large Cap ETF (GRNY) allows investors to invest based on Tom Lee's active strategy.
Rare-earth metals have become a hot topic in the world, but is it a good idea to buy an ETF dedicated to the niche?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback